Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease

Prostaglandins and Other Lipid Mediators

Volumn 113-115, Issue , 2014, Pages 45-51

  Dreisbach, Albert W ^a   Smith, Stanley V ^a   Kyle, Patrick B ^a   Ramaiah, Manjunath ^c   Amenuke, Margaret ^a   Garrett, Michael R ^a   Lirette, Seth T ^b   Griswold, Michael E ^b   Roman, Richard J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c Hattiesburg Clinic   (United States)

Author keywords

Biomarkers; Chronic kidney disease; Cytochrome P450; diHETEs; EETs; Eicosanoids; HETE

Indexed keywords

19 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; BIOTRANSFORMATION; CHRONIC KIDNEY DISEASE; CREATININE URINE LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; MALE; METABOLITE; PROTEINURIA; URINALYSIS; URINARY EXCRETION; URINE LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; ETHNOLOGY; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; UNITED STATES; URINE;

ADULT; AFRICAN AMERICANS; CREATININE; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

EID: 84909997273     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2014.08.002     Document Type: Article

References (32)

1. C.A. Jones Hypertension and renal dysfunction: NHANES III J. Am. Soc. Nephrol. 14 2011 S71 S75
2. US Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2011
3. J.H. Capdevila, J.R. Flack, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of arachidonate mono-oxygenase J. Lipid Res. 41 2000 163 181
4. A. Sarkis, B. Lopez, and R.J. Roman Role of 20-hydroxyeicosatetraenoic acid and epoxyeicos-atrienoic acids in hypertension Curr. Opin. Nephrol. Hypertens. 13 2004 205 214
5. C.C. Wu, T. Gupta, V. Garcia, Y. Ding, and M.L. Schwartzman 20-HETE and blood pressure regulation: clinical implications Cardiol. Rev. 2013 (Epub ahead of print)
6. S. Eid, R. Maalouf, and A. Jaffa 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway PLOS ONE 8 2013 e7029
7. J. Quilley, and J.C. McGiff Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol. Sci. 21 2000 121 124
8. J. Cheng, C.-C. Wu, and K.H. Gotlinger 20-Hydroxy-5,8,11,14-eicosatetrenoic acid mediates endothelial dysfunction via IkB kinase-dependent endothelial nitric-oxide synthase uncoupling J. Pharmacol. Exp. Ther. 322 2010 57 65
9. J.V. Gainer, A. Bellamine, and E.P. Dawson Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension Circulation 111 2005 63 69
10. B. Mayer, W. Lieb, and A. Götz Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy Hypertension 46 2005 766 771
11. B. Mayer, W. Lieb, and A. Götz Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction J. Hypertens. 24 2006 1965 1970
12. F. Elijovich, and C.L. Laffer The relationship between CYP4A11 and human hypertension J. Hypertens. 26 2008 1712 1714
13. Z. Fu, T. Nakayama, and N. Sato Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject Endocrine 33 2008 215 222
14. J.V. Gainer, M.S. Lipkowitz, and C. Yu AASK Study Group: association of a CYP4A11 variant and blood pressure in black men J. Am. Soc. Nephrol. 9 2008 1606 1612
15. Z. Fu, T. Nakayama, and N. Sato A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men J. Hypertens. 26 2008 453 461
16. C.L. Laffer, J.V. Gainer, and M.R. Waterman The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension Hypertension 51 2008 767 772
17. N.C. Ward, I.J. Tsai, and A. Barden A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure Hypertension 51 2008 1393 1398
18. H. Liu, Y. Zhao, and D. Nie Association of a functional cytochrome P4504F2 haplotype with urinary 20-HETE and hypertension J. Am. Soc. Nephrol. 19 7 2008 14 721
19. D.E. Stec, R.J. Roman, A. Flasch, and M.J. Rieder Functional polymorphism in human CYP4F2 decreases 20-HETE production Physiol. Genomics 30 2007 74 81
20. C. Fava, M. Montagnana, and P. Almgren The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure Hypertension 52 2008 373 380
21. H. Ding, G. Cui, and L. Zhang Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population Pharmacogenet. Genomics 20 2010 187 194
22. Z. Fu, T. Nakayama, and N. Sato A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men Am. J. Hypertens. 21 2008 1216 1223
23. H. Liu, Y.Y. Zhao, and W. Gong Correlation analysis and Identification of G421C in regulatory region of CYP4F2 gene with essential hypertension Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28 2006 143 147
24. Z. Fu, T. Nakayama, and N. Sato Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects Hypertens. Res. 231 2008 1719 1726
25. P. Fidelis, L. Wilson, K. Thomas, M. Villalobos, and A.O. Oyekan Renal function and vasomotor activity in mice lacking the Cyp4a14 gene Exp. Biol. Med. 235 2010 365 1374
26. L.D. Orozco, H. Liu, and E. Perkins 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries J. Pharmacol. Exp. Ther. 346 1 2013 67 74
27. K.A. McGurk, C.H. Brierley, and B. Burchell Drug glucuronidation by human renal UDP-glucuronyl transferases Biochem. Pharmacol. 55 1998 1005 1012
28. N.C. Ward, I.-J. Tsai, and A. Barden A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure Hypertension 51 2008 1393 1400
29. N.C. Ward, J. Rivera, and J. Hodgson Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction n humans Circulation 110 2004 438 443
30. C.L. Laffer, M. Lanido-Schwartzman, M.-H. Wang, A. Nasjletti, and F. Elijovich Differential regulation of natriuresis by 20-hydroxyeicosatetreanoic acid in human salt-sensitive versus salt-resistant hypertension Circulation 107 2003 574 578
31. K. Gilbert, H. Nian, C. Yu, J.M. Luther, and N.J. Brown Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension J. Hypertens. 31 4 2013 820 829
32. K.N. Theken, R.N. Shuck, and M.L. Edin Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic disease Atherosclerosis 222 2012 530 536